⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
TIVC News
Tivic Health Systems, Inc. Common Stock
DealFlow Discovery Conference Announces Initial Lineup of Presenting Companies Ahead of Next Week's Event
accessnewswire.com
COE
ACCS
ASNS
DRTS
AREB
BKYI
FUFU
CJMB
DVLT
FBLG
MEHA
HCTI
INDO
JUNS
KAPA
LIXT
MYSZ
NNVC
HOVR
NOMA
OPTT
OWLS
PERF
PHIO
PROP
PRPO
SJ
LITM
SOPA
SNGX
XHLD
TYGO
TIVC
TRX
WGRX
WWR
ZENA
FLGC
DealFlow Discovery Conference Announces Initial Lineup of Presenting Companies Ahead of Next Week's Event
accessnewswire.com
COE
ACCS
ASNS
DRTS
AREB
BKYI
FUFU
CJMB
DVLT
FBLG
MEHA
HCTI
INDO
JUNS
KAPA
LIXT
MYSZ
NNVC
HOVR
NOMA
OPTT
OWLS
PERF
PHIO
PROP
PRPO
SJ
LITM
SOPA
SNGX
XHLD
TYGO
TIVC
TRX
WGRX
WWR
ZENA
FLGC
DealFlow Discovery Conference Announces Initial Lineup of Presenting Companies Ahead of Next Week's Event
accessnewswire.com
COE
ACCS
ASNS
DRTS
AREB
BKYI
FUFU
CJMB
DVLT
FBLG
MEHA
HCTI
INDO
JUNS
KAPA
LIXT
MYSZ
NNVC
HOVR
NOMA
OPTT
OWLS
PERF
PHIO
PROP
PRPO
SJ
LITM
SOPA
SNGX
XHLD
TYGO
TIVC
TRX
WGRX
WWR
ZENA
FLGC
Presenting on Emerging Growth Conference 89 Day 2 on January 22; Register to live stream
globenewswire.com
RADX
OPHC
DGXX
CLNN
DEVS
ZENA
IMRN
MIGI
TIVC
SBC
Presenting on Emerging Growth Conference 89 Day 2 on January 22; Register to live stream
globenewswire.com
RADX
OPHC
DGXX
CLNN
DEVS
ZENA
IMRN
MIGI
TIVC
SBC
Tivic CEO To Present at the Upcoming Emerging Growth's January 2026 Virtual Conference
accessnewswire.com
TIVC
Presenting on Emerging Growth Conference 89 Day 1 on January 21; Register to live stream
globenewswire.com
RADX
OPHC
DEVS
CLNN
DGXX
ZENA
IMRN
MIGI
TIVC
SBC
Tivic Delivers 200x Scale-up in Manufacturing for Lead Drug Candidate Entolimod(TM) And Achieves Reproducible Yields, Potency and Purity
accessnewswire.com
TIVC
Tivic Announces Special Webcast To Discuss Its Recent Acquisition of CDMO Assets - Highlighting Near-Term Strategic Potential and Immediate Contributions to Accelerated Drug Development Timelines
accessnewswire.com
TIVC
Tivic Acquires Ready-to-Scale cGMP Manufacturing and Development Assets to Accelerate Commercialization of Entolimod; Tivic Growth Backed By $90M+ Financing Package
accessnewswire.com
TIVC